Âé¶¹´«Ã½Ó³»­

Âé¶¹´«Ã½Ó³»­

Explore the latest content from across our publications

Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

Joubert’s Syndrome with dystonic-ataxic tremor: a novel phenotypic variant
Movement Disorders
P7 - Poster Session 7 (5:30 PM-6:30 PM)
3-014

To describe the case of a 17-year-old developmentally delayed male presenting with two years of asymmetric tremor and gait impairment.

The patient was born at 38 weeks with macrocephaly. He had significant motor and language developmental delay. At age 15 he developed a new jerky left arm and head tremor that progressed to his left leg. His left foot turned inward; foot drag impaired his gait with frequent falls. Symptoms progressed and are now constant without clear triggers or variation. There was no benefit from anti-psychotic discontinuation or trials of levodopa, trihexyphenidyl, propranolol, clonidine or baclofen. There is no significant family history.

On exam, he has macrocephaly, frontal bossing, hypertelorism and depressed nasal bridge. He is averbal, can follow simple commands, with limited eye movements. He has head titubation and a moderate amplitude jerky irregular tremor of the left hemi-body, mild of the right arm; present at rest but action-exacerbated. Tone is increased throughout with spasticity, diffuse hyperreflexia, and clonus. Gait is spastic with left foot inversion dystonia.

Workup was negative for electrolyte abnormalities, Wilson’s disease, inborn errors of metabolism and mitochondrial disease. MRI Brain showed Molar Tooth Sign: elongated superior cerebellar peduncles and vermian hypoplasia. Genetic testing revealed a de novo 3.7Mb  interstitial deletion of 32 protein-coding genes. Two deleted genes, SUFU and ARL3, are implicated in Joubert Syndrome (JS). SUFU cases are phenotypically similar (facial dysmorphisms, intellectual disability, ataxic gait), though without tremor.

This is the first report of the unique phenotype of a late-onset asymmetric dystonic-ataxic tremor in an individual with imaging and genetics indicative of JS, adding to the syndrome’s phenotypically and genetically heterogeneous spectrum.

Authors/Disclosures
Danielle Larson, MD (Northwestern University, Feinberg School of Medicine)
PRESENTER
Dr. Larson has received personal compensation in the range of $0-$499 for serving as a Consultant for Acadia Pharmaceuticals.
No disclosure on file
Joanna S. Blackburn, MD (Ann& Robert H. Lurie Children'S Hospital of Chicago) Dr. Blackburn has nothing to disclose.
Niccolo Mencacci, MD, PhD (Northwestern University) The institution of Dr. Mencacci has received research support from NIH.